US2001A
(en)
*
|
|
1841-03-12 |
|
Sawmill |
US2215233A
(en)
*
|
1937-11-13 |
1940-09-17 |
Simon L Ruskin |
Iron compound of nucleotides and their organic hydrolytic decomposition products and method of making same
|
US3906092A
(en)
*
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
US3911117A
(en)
*
|
1971-12-20 |
1975-10-07 |
Fredrik Ender |
Raw fish and iron chelated with glutamic or ribonucleic acid in a mink diet
|
US3914450A
(en)
*
|
1973-04-09 |
1975-10-21 |
Anheuser Busch |
Concentrated extract of yeast and processes of making same
|
US4469863A
(en)
*
|
1980-11-12 |
1984-09-04 |
Ts O Paul O P |
Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
|
DE3280400D1
(de)
|
1981-10-23 |
1992-06-04 |
Molecular Biosystems Inc |
Oligonukleotides heilmittel und dessen herstellungsverfahren.
|
US5023243A
(en)
*
|
1981-10-23 |
1991-06-11 |
Molecular Biosystems, Inc. |
Oligonucleotide therapeutic agent and method of making same
|
ES507187A0
(es)
*
|
1981-11-16 |
1983-01-01 |
Union Ind Y Agro Ganader S A U |
Procedimiento de obtencion de una leche humanizada adiciona-da de nucleotidos con destino a la alimentacion infantil.
|
JPS60126220A
(ja)
*
|
1983-12-09 |
1985-07-05 |
Otsuka Pharmaceut Factory Inc |
核酸成分組成物
|
US4741914A
(en)
*
|
1984-11-13 |
1988-05-03 |
Ajinomoto Co., Inc. |
Flavor enhancing seasoning containing deodorized garlic extract and process
|
US4956296A
(en)
*
|
1987-06-19 |
1990-09-11 |
Genex Corporation |
Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
|
JPS62275667A
(ja)
*
|
1986-05-22 |
1987-11-30 |
Ajinomoto Co Inc |
こく味調味料又はこく味の増強された食品の製造法
|
US4963387A
(en)
*
|
1987-05-20 |
1990-10-16 |
Chugai Seiyaku Kabushiki Kaisha |
Salt substitute and foodstuffs containing same
|
ES2007350A6
(es)
*
|
1987-05-29 |
1989-06-16 |
Ganadera Union Ind Agro |
Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
|
JP2656571B2
(ja)
*
|
1987-11-17 |
1997-09-24 |
三井東圧化学株式会社 |
テトラフェニルチオフェン誘導体およびこれを含有する電子写真用感光体
|
US5268365A
(en)
*
|
1988-03-11 |
1993-12-07 |
Rudolph Frederick B |
Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
|
CA1336174C
(en)
*
|
1988-07-22 |
1995-07-04 |
Ronald Peter Potman |
Method for the preparation of a yeast extract said yeast extract, its use as a food flavour and a food composition comprising the yeast extract
|
US5231085A
(en)
*
|
1988-10-31 |
1993-07-27 |
Sandoz Ltd. |
Compositions and methods for the enhancement of host defense mechanisms
|
US5786189A
(en)
*
|
1989-11-29 |
1998-07-28 |
Smithkline Beecham Biologicals (S.A.) |
Vaccine
|
US5248670A
(en)
*
|
1990-02-26 |
1993-09-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotides for inhibiting herpesviruses
|
US5514577A
(en)
|
1990-02-26 |
1996-05-07 |
Isis Pharmaceuticals, Inc. |
Oligonucleotide therapies for modulating the effects of herpes viruses
|
EP0468520A3
(en)
|
1990-07-27 |
1992-07-01 |
Mitsui Toatsu Chemicals, Inc. |
Immunostimulatory remedies containing palindromic dna sequences
|
US5234811A
(en)
*
|
1991-09-27 |
1993-08-10 |
The Scripps Research Institute |
Assay for a new gaucher disease mutation
|
CA2106386A1
(en)
|
1991-04-18 |
1992-10-19 |
Barbara C. F. Chu |
Oligodeoxynucleotides and oligonucleotides useful as decoys for proteins which selectively bind to defined dna sequences
|
US6022853A
(en)
*
|
1991-08-30 |
2000-02-08 |
Creative Biomolecules, Inc. |
Morphogen-enriched dietary composition
|
AU3628193A
(en)
|
1992-02-18 |
1993-09-13 |
Gesellschaft Fur Biotechnologische Forschung Mbh |
Dysentery vaccine stimulating an immune response against shigatoxin, plasmids and host strains for it
|
EP0633929B1
(de)
*
|
1992-04-01 |
2004-03-03 |
The Rockefeller University |
Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung
|
EP0572735B1
(de)
|
1992-06-04 |
1998-11-25 |
VYSIS, Inc. |
Nukleinsäuresonden zum Nachweis von Mycoplasma fermentans
|
US5585479A
(en)
*
|
1992-07-24 |
1996-12-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Antisense oligonucleotides directed against human ELAM-I RNA
|
JPH08504570A
(ja)
*
|
1992-10-05 |
1996-05-21 |
ハイブライドン インコーポレイテッド |
治療用抗hivオリゴヌクレオチドと薬剤
|
US5650156A
(en)
*
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
WO1995001097A1
(en)
*
|
1993-06-30 |
1995-01-12 |
Board Of Regents, The University Of Texas System |
Nucleotide preparation and uses thereof in wound healing
|
US5804566A
(en)
*
|
1993-08-26 |
1998-09-08 |
The Regents Of The University Of California |
Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
|
US5849719A
(en)
*
|
1993-08-26 |
1998-12-15 |
The Regents Of The University Of California |
Method for treating allergic lung disease
|
GB9326425D0
(en)
|
1993-12-24 |
1994-02-23 |
Secr Defence |
Vaccine compositions
|
US5700590A
(en)
*
|
1994-01-10 |
1997-12-23 |
Abbott Laboratories |
Nutritional formula with ribo-nucleotides
|
US5488039A
(en)
*
|
1994-01-10 |
1996-01-30 |
Abbott Laboratories |
Method for the production of an enteral formula containing ribo-nucleotides
|
US5602109A
(en)
*
|
1994-01-10 |
1997-02-11 |
Abbott Laboratories |
Method to enhance the immune system of a human
|
US5492899A
(en)
*
|
1994-01-10 |
1996-02-20 |
Abbott Laboratories |
Infant nutritional formula with ribo-nucleotides
|
DE69517836T2
(de)
*
|
1994-03-18 |
2001-03-01 |
Ajinomoto Kk |
Proteinhaltiges Mittel zur Verbesserung der Geschmacksqualität von Lebensmitteln
|
WO1995026204A1
(en)
*
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US6429199B1
(en)
*
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
CA2194761C
(en)
|
1994-07-15 |
2006-12-19 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5591721A
(en)
*
|
1994-10-25 |
1997-01-07 |
Hybridon, Inc. |
Method of down-regulating gene expression
|
US6428788B1
(en)
*
|
1995-03-15 |
2002-08-06 |
Penn State University |
Compositions and methods for specifically targeting tumors
|
US5614191A
(en)
*
|
1995-03-15 |
1997-03-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
IL-13 receptor specific chimeric proteins and uses thereof
|
JP3580900B2
(ja)
*
|
1995-04-20 |
2004-10-27 |
ホクレン農業協同組合連合会 |
α−グルコシダーゼ阻害剤を含む糖を主体とする組成物を有効成分とする食品及び飼料
|
US5612060A
(en)
*
|
1995-05-25 |
1997-03-18 |
Alexander; J. Wesley |
Enhancement of transplant graft survival through nutritional immunomodulation and immunosuppressive therapy
|
US5976580A
(en)
*
|
1995-06-07 |
1999-11-02 |
Novus International, Inc. |
Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
|
GB9525902D0
(en)
*
|
1995-12-16 |
1996-02-21 |
Zeneca Ltd |
Fungus
|
EP0879284B1
(de)
|
1996-01-30 |
2009-07-29 |
The Regents of The University of California |
Expressionsvektoren, die eine antigen-spezifische immunantwort induzieren, und methoden für ihre verwendung.
|
US5895652A
(en)
*
|
1996-07-29 |
1999-04-20 |
Longevity Institute International |
Method of metabolic adjuvanation and cellular repair
|
US5856462A
(en)
|
1996-09-10 |
1999-01-05 |
Hybridon Incorporated |
Oligonucleotides having modified CpG dinucleosides
|
ATE292980T1
(de)
*
|
1996-10-11 |
2005-04-15 |
Univ California |
Immunostimulierende oligonucleotidekonjugate
|
EP0855184A1
(de)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmazeutisches Präparat das ein Polynukleotid und ein Antigen enthält, insbesondere zur Impfung
|
WO1998037919A1
(en)
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
ATE441432T1
(de)
*
|
1997-03-10 |
2009-09-15 |
Ottawa Hospital Res Inst |
Verwendung von nicht-methyliertem cpg dinukleotid in kombination mit aluminium als adjuvantien
|
US6426334B1
(en)
*
|
1997-04-30 |
2002-07-30 |
Hybridon, Inc. |
Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal
|
EP1003531B1
(de)
*
|
1997-05-20 |
2007-08-22 |
Ottawa Health Research Institute |
Verfahren zur Herstellung von Nukleinsäurekonstrukten
|
CA2291483C
(en)
*
|
1997-06-06 |
2012-09-18 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US6589940B1
(en)
*
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
US5922766A
(en)
*
|
1997-07-02 |
1999-07-13 |
Acosta; Phyllis J. B. |
Palatable elemental medical food
|
EP1009413B1
(de)
|
1997-09-05 |
2007-02-14 |
The Regents Of The University Of California |
Verwendung von immunerregenden oligonukleotiden zur vorbeugung oder behandlung von asthma
|
ES2284247T3
(es)
*
|
1998-04-03 |
2007-11-01 |
University Of Iowa Research Foundation |
Metodos y productos para estimular el sistema inmunitario usando oligonucleotidos y citoquinas inmunoterapeuticos.
|
PL345241A1
(en)
|
1998-05-06 |
2001-12-03 |
Upjohn Co |
Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate
|
AU3884199A
(en)
*
|
1998-05-06 |
1999-11-23 |
Ottawa Health Research Institute |
Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
|
IL139646A0
(en)
*
|
1998-05-14 |
2002-02-10 |
Coley Pharm Group Inc |
Methods for regulating hematopoiesis using cpg-oligonucleotides
|
EP1733735B1
(de)
|
1998-05-22 |
2017-03-22 |
Ottawa Hospital Research Institute |
Verfahren und Produkte zur Induktion von mukosaler Immunität
|
US7227011B2
(en)
|
1998-06-04 |
2007-06-05 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acid vaccines for prevention of flavivirus infection
|
US6562798B1
(en)
*
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
WO2000006588A1
(en)
|
1998-07-27 |
2000-02-10 |
University Of Iowa Research Foundation |
STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
|
US20010034330A1
(en)
|
1998-08-10 |
2001-10-25 |
Charlotte Kensil |
Innate immunity-stimulating compositions of CpG and saponin and methods thereof
|
EP1832657B1
(de)
*
|
1998-09-09 |
2012-10-24 |
Genzyme Corporation |
Methylierung von Plasmid-Vektoren
|
US20020065236A1
(en)
*
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
US20020142974A1
(en)
|
1998-09-11 |
2002-10-03 |
Leonard D. Kohn |
Immune activation by double-stranded polynucleotides
|
EP1119375A4
(de)
|
1998-10-05 |
2005-02-02 |
Regetns Of The University Of C |
Verfahren und adjuvantien für die stimulierung von mukosaler immunität
|
AU6425999A
(en)
|
1998-10-09 |
2000-05-01 |
Dynavax Technologies Corporation |
Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens
|
CA2359636A1
(en)
*
|
1999-01-22 |
2000-07-27 |
Andrew W. Taylor |
Activation of regulatory t cells by alpha-melanocyte stimulating hormone
|
US6977245B2
(en)
*
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
EP1176966B1
(de)
*
|
1999-04-12 |
2013-04-03 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Oligodeoxynukleotide und deren verwendung zur induktion einer immunreaktion
|
AU4642600A
(en)
|
1999-04-15 |
2000-11-02 |
Regents Of The University Of California, The |
Methods and compositions for use in potentiating antigen presentation by antigenpresenting cells
|
EP1177439B1
(de)
|
1999-04-29 |
2004-09-08 |
Coley Pharmaceutical GmbH |
Screening nach modulatoren der funktion von immunstimulatorischer dna
|
DE60023300T2
(de)
|
1999-06-29 |
2006-07-06 |
Glaxosmithkline Biologicals S.A. |
Verwendung von cpg als adjuvans für hivimpstoff
|
US6514948B1
(en)
*
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
ATE419869T1
(de)
|
1999-08-19 |
2009-01-15 |
Dynavax Tech Corp |
Methode zur modulierung eines immunantwortes mit immunstimulierenden sequencen und zusammensetzungen dafür
|
AP1775A
(en)
*
|
1999-09-25 |
2007-08-28 |
Univ Iowa Res Found |
Immunostimulatory nucleic acids.
|
MXPA02003059A
(es)
|
1999-09-27 |
2002-09-30 |
Univ Iowa Res Found |
Metodos relacionados con interferon inducido por acido nucleico inmunoestabilizador.
|
US6949520B1
(en)
*
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
US20020091095A1
(en)
*
|
1999-12-13 |
2002-07-11 |
Phillips Nigel C. |
Modulation of Fas and FasL expression
|
US20020006403A1
(en)
*
|
1999-12-14 |
2002-01-17 |
Xue-Zhong Yu |
CD28-specific antibody compositions for use in methods of immunosuppression
|
ATE378348T1
(de)
*
|
2000-01-14 |
2007-11-15 |
Us Health |
Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
|
AU3108001A
(en)
|
2000-01-20 |
2001-12-24 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
AT409085B
(de)
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
US6552006B2
(en)
*
|
2000-01-31 |
2003-04-22 |
The Regents Of The University Of California |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
EP1259264A4
(de)
*
|
2000-02-23 |
2005-08-31 |
Univ California |
VERFAHREN ZUR BEHANDLUNG VON ENTZüNDLICHEN DARMERKRANKUNGEN UND ANDEREN FORMEN VON GASTROINTESTINALEN ENTZüNDUNGEN
|
AU2001239873A1
(en)
*
|
2000-02-24 |
2001-09-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adjuvant treatment by in vivo activation of dendritic cells
|
US20020156033A1
(en)
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
US7157437B2
(en)
|
2000-03-10 |
2007-01-02 |
Dynavax Technologies Corporation |
Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
|
US7129222B2
(en)
*
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
US20020098199A1
(en)
|
2000-03-10 |
2002-07-25 |
Gary Van Nest |
Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
|
US20020028784A1
(en)
*
|
2000-03-10 |
2002-03-07 |
Nest Gary Van |
Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences
|
US20020107212A1
(en)
|
2000-03-10 |
2002-08-08 |
Nest Gary Van |
Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences
|
US20010046967A1
(en)
*
|
2000-03-10 |
2001-11-29 |
Gary Van Nest |
Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
|
AU2001249609A1
(en)
*
|
2000-03-28 |
2001-10-08 |
Department Of Veterans Affairs |
Methods for increasing a cytotoxic T lymphocyte response in vivo
|
EP1278550A4
(de)
|
2000-04-07 |
2004-05-12 |
Univ California |
Synergistische verbesserungen von polynucleotid impfstoffen
|
EP1292331A2
(de)
*
|
2000-06-07 |
2003-03-19 |
Biosynexus Incorporated |
Immunstimulierende rns/dns hybridmolekule
|
US20020165178A1
(en)
|
2000-06-28 |
2002-11-07 |
Christian Schetter |
Immunostimulatory nucleic acids for the treatment of anemia, thrombocytopenia, and neutropenia
|
JP5511117B2
(ja)
|
2000-07-27 |
2014-06-04 |
チルドレンズ ホスピタル アンド リサーチ センター アット オークランド |
髄膜炎菌に起因する疾患に対する広域防御のためのワクチン
|
US20020198165A1
(en)
|
2000-08-01 |
2002-12-26 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of gastric ulcers
|
US7811592B2
(en)
|
2000-08-16 |
2010-10-12 |
Auburn University |
Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
|
US20020091097A1
(en)
*
|
2000-09-07 |
2002-07-11 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of sexually transmitted diseases
|
WO2002026757A2
(en)
|
2000-09-26 |
2002-04-04 |
Hybridon, Inc. |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
CN101428006A
(zh)
|
2000-09-28 |
2009-05-13 |
诺华疫苗和诊断公司 |
微粒体组合物及其生产方法
|
AU2002228932A1
(en)
|
2000-10-24 |
2002-05-06 |
Schering Corporation |
Maturation of dendritic cells
|
KR100331952B1
(ko)
|
2000-11-23 |
2002-04-09 |
최수일 |
다목적 고기능성 알칼리 용액 조성물 및 그 제조방법과 비특이 면역증강제로서의 용도
|
US7666674B2
(en)
*
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
AU2002361468A1
(en)
*
|
2001-08-14 |
2003-03-18 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human S |
Method for rapid generation of mature dendritic cells
|
AU2002366710A1
(en)
*
|
2001-12-20 |
2003-07-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
US8043622B2
(en)
*
|
2002-10-08 |
2011-10-25 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
|
US7758876B2
(en)
*
|
2002-11-01 |
2010-07-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
|
US20100113565A1
(en)
*
|
2004-12-08 |
2010-05-06 |
Gorden Keith B |
Immunostimulatory combinations and methods
|
WO2006065751A2
(en)
*
|
2004-12-13 |
2006-06-22 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
|
JP5481068B2
(ja)
*
|
2005-08-31 |
2014-04-23 |
アメリカ合衆国 |
CpGオリゴデオキシヌクレオチドによって誘発される免疫応答を変化させる方法
|
US8053422B2
(en)
*
|
2008-12-04 |
2011-11-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Anti-cancer oligodeoxynucleotides
|